Vaginitis in adolescent girls.
D000293:Adolescent; D001888:Boric Acids / Q000627:therapeutic use; D002175:Candida / Q000302:isolation & purification; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy / Q000382:microbiology; D002648:Child; D004757:Enterobius / Q000302:isolation & purification; D005260:Female; D005547:Foreign Bodies / Q000150:complications; D005549:Foreign-Body Reaction / Q000150:complications; D006190:Haemophilus / Q000302:isolation & purification; D006566:Herpesviridae Infections / Q000150:complications; D006801:Humans; D006920:Hygiene; D006967:Hypersensitivity / Q000150:complications; D008795:Metronidazole / Q000627:therapeutic use; D010123:Oxyuriasis / Q000150:complications; D014247:Trichomonas Vaginitis / Q000382:microbiology; D014246:Trichomonas vaginalis / Q000188:drug therapy / Q000302:isolation & purification; D014552:Urinary Tract Infections / Q000150:complications; D002579:Uterine Cervical Erosion / Q000150:complications; D014627:Vaginitis / Q000209:etiology*; D014848:Vulvovaginitis / Q000209:etiology
D001888:Boric Acids; D008795:Metronidazole